Emerging Growth Research Reiterates Buy-Emerging Rating and $9.00 Price Target on Virtuix Following Strong Fiscal Q1 2027 Results
Rhea-AI Summary
Emerging Growth Research reaffirmed its Buy-Emerging rating and 12‑month $9.00 price target on Virtuix (NASDAQ: VTIX), implying about 644% upside from the August 25, 2026 close of $1.21. The call follows Virtuix’s fiscal Q1 2027 revenue of $0.8 million, down 26% year-over-year from $1.0 million but above the firm’s $0.5 million estimate, driven by new orders after the June 2026 Meta partnership.
According to Emerging Growth Research, new orders rose about 72% year-over-year and about 150% since the Meta launch. Gross profit increased to $0.23 million, with gross margin expanding from 17% to about 30%, while EPS improved sequentially to $(0.22). The firm highlights access to roughly 20 million Meta Quest users, growing U.S. defense use, potential defense acquisitions in the $10–$50 million revenue range, and estimated revenue growth of about 19% in fiscal 2027 and 275% in fiscal 2028. Valuation work using 2028E peer Price/Sales and discounted cash flow yields an average value of about $8.96 per share, supporting the $9.00 target, while noting execution, defense, geopolitical, and financing risks.
Positive
- Q1 2027 revenue $0.8M, beating Emerging Growth Research’s $0.5M estimate despite tough comparison
- New orders +72% YoY and about +150% since June 2026 Meta partnership launch
- Gross margin expansion from 17% to about 30% in fiscal Q1 2027
- Sequential EPS improvement to $(0.22) from $(0.30) in prior quarter
- Large implied upside: $9.00 target vs. $1.21 close (~644% potential, per Emerging Growth Research)
- Estimated revenue growth of ~19% in fiscal 2027 and ~275% in fiscal 2028
Negative
- Revenue down 26% YoY in fiscal Q1 2027, $0.8M vs. $1.0M prior-year period
- Operating expenses increased as a newly public company, with ongoing operating losses despite sequential improvement
- Financing risk: additional capital may be required as Virtuix invests in higher SG&A expenses
- Potential share supply overhang after post-IPO lockup expiration, per Emerging Growth Research’s risk summary
- Execution and contract risks in consumer adoption, defense contracting, and new robotics, space, and healthcare markets
Key Figures
Previous Earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 19 | Q1 earnings results | Negative | -22.5% | Revenue declined while net loss widened despite order and gross-margin improvements. |
| Jul 02 | Q4 earnings update | Positive | -7.4% | Meta distribution partnership and projected fiscal growth supported the research update. |
| Mar 05 | Q3 earnings results | Positive | -8.5% | Nine-month sales growth and margin expansion accompanied broader consumer and defense initiatives. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Tag-matched earnings releases had produced negative 24-hour reactions despite reported growth initiatives or operational improvements.
Key Terms
adjusted ebitda financial
sbir program regulatory
price/sales methodology financial
discounted cash flow analysis financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK CITY, NY / ACCESS Newswire / August 26, 2026 / Emerging Growth Research today announced the release of its Fiscal Q1 2027 Quarterly Update on Virtuix Holdings Inc. (NASDAQ:VTIX), reiterating its Buy-Emerging rating and 12-month price target of
The quarterly update highlights what Emerging Growth Research believes is the beginning of an important growth inflection for Virtuix following a transformational fiscal 2026. While fiscal Q1 2027 revenue was technically down year-over-year due primarily to the comparison against a large legacy preorder backlog in the prior-year period, revenue of
Emerging Growth Research believes Virtuix is transitioning into a growth company, supported by its market-leading, patent-protected, AI-driven technology platform and multi-market strategy spanning consumer virtual reality, defense, robotics, space, and healthcare. The firm's bullish outlook is further supported by the Company's recurring software and gaming revenue opportunities, new Meta distribution channel, U.S. defense initiatives, and potential strategic defense acquisitions.
Key Highlights from the Quarterly Update
• Fiscal Q1 2027 Revenue Exceeded Expectations
Virtuix reported fiscal Q1 2027 revenue of approximately
New orders increased approximately
• Meta Partnership Provides Significant Consumer Market Access
Virtuix's partnership with Meta provides access to approximately 20 million Meta Quest headset users, including approximately 6 million active users. Omni One is now featured on Meta's website, creating a substantially broader distribution channel for Virtuix's flagship platform.
Emerging Growth Research believes this relationship could become an important catalyst for consumer adoption, with Virtuix also expanding its presence in Europe and in Canada through an online presence.
• Defense Opportunity Continues to Expand
Virtuix continues to advance its AI-powered Virtual Terrain Walk platform for national defense applications. The Company was selected by the U.S. Air Force SBIR program for Phase 1 funding, while the Marines, Army, and Navy are also beginning to use Omni One for various applications.
In addition, management is evaluating potential defense acquisitions in the approximately
• Gross Margin Improved Significantly
Gross profit increased to approximately
Although operating expenses increased as Virtuix absorbs the costs associated with being a newly public company, operating losses improved sequentially from fiscal Q4 2026. Adjusted EBITDA also improved sequentially, while EPS improved to
• Potential "Hockey Stick" Revenue Growth Ahead
Emerging Growth Research now estimates approximately
The firm believes Virtuix could reach a significant revenue inflection point beginning in calendar 2027 and that longer-term estimates may prove conservative if the Company successfully executes across its consumer and defense opportunities.
• Shares Remain Significantly Undervalued
Despite the Company's growth opportunities, Emerging Growth Research believes VTIX shares continue to trade at a substantial valuation discount.
Based on its valuation analysis, the firm's 2028E peer Price/Sales methodology produces a
At the August 25, 2026 closing price of
• Near-Term Risks Remain
The report identifies several risks, including execution of consumer adoption and growth initiatives, uncertainty surrounding defense contracting, expansion into new robotics, space and healthcare applications, geopolitical and tariff exposure related to manufacturing and international expansion, and potential additional share supply following the expiration of the Company's post-IPO lockup period.
The report also notes that additional financing may ultimately be required as Virtuix continues investing in higher SG&A expenses, although debt and warrants are expected to convert or expire during calendar 2026.
Emerging Growth Research believes these risks are outweighed by Virtuix's expanding consumer and defense opportunities, proprietary technology, new Meta distribution relationship, and potential for substantial revenue growth beginning in fiscal 2027 and accelerating thereafter.
The report concludes that Virtuix's combination of AI-driven extended reality technology, consumer VR adoption, defense applications, recurring software and gaming revenue, and potential strategic M&A creates a compelling long-term growth opportunity. Emerging Growth Research reiterates its Buy-Emerging rating and
For a copy of the full Fiscal Q1 2027 Quarterly Update, please visit:
https://storage.googleapis.com/accesswire/media/1212036/vtixq1fy27-quarerly-update-082626.pdf
or
https://emerginggrowth.com/profile/vtix/ (Quarterly Update available on the Company profile page on the right as you scroll down)
About Virtuix Holdings Inc.
Virtuix Holdings Inc. (NASDAQ:VTIX) is a leading manufacturer of AI-driven, full-body simulation systems for consumer, enterprise, and defense markets. The Company's premier portfolio of "Omni" omni-directional treadmills enables players to walk and run in 360 degrees without boundaries inside AI-generated worlds. With a focus on immersive entertainment, defense training, and enterprise applications, Virtuix continues to push the boundaries of full-body XR and AI-driven immersive experiences for users worldwide. For more information, please visit www.Virtuix.com.
About Emerging Growth Research
Emerging Growth Research is an independent equity research firm focused on providing institutional-quality analysis on emerging and growth-stage companies. Through its comprehensive research platform, Emerging Growth Research delivers objective investment analysis designed to enhance transparency, improve investor understanding, and broaden market awareness. The firm provides ongoing research coverage for companies presenting on the Emerging Growth Conference platform.
Contact:
Emerging Growth Research
Research@EmergingGrowth.com
www.EmergingGrowth.com
Forward-Looking Statements
This press release contains forward-looking statements concerning business operations, financial performance, revenue projections, defense contracting opportunities, merger and acquisition prospects, valuation estimates, and future growth expectations. These statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied. Important risk factors include, but are not limited to, consumer adoption rates, defense contract timing and procurement delays, geopolitical and tariff exposure, potential share dilution, the expiration of the IPO lock-up period, and the Company's ability to successfully execute its growth strategy across both consumer and defense markets.
SOURCE: Virtuix Holdings Inc.
View the original press release on ACCESS Newswire